Top Industry Leaders in the Allergy Vaccine Market
Merck Sharp & Dohme (MSD) Acquired Aimmune Therapeutics, gaining access to their peanut allergy vaccine, Palforzia, and strengthening their allergy treatment portfolio.
ALK-Abello Partnered with Regeneron on their investigational IL-4Rฮฑ antagonist, REGN1679, to explore its potential in treating severe allergic diseases.
Circassia Pharmaceuticals Received FDA approval for their grass pollen sublingual tablet allergy vaccine, Grazaxยฎ, expanding access to this treatment option.
Stallergenes Greer Launched their first sublingual tablet allergy vaccine for ragweed in the US, Oralairยฎ (ambrosia artemisiifolia sublingual allergenic extract), further diversifying their product portfolio.
Immuno Laboratories Developed the Viaskinยฎ Peanut, a next-generation epicutaneous allergy patch for peanut allergies, currently undergoing Phase 3 clinical trials.
LEO Pharma Announced positive Phase 2b results for their investigational peanut allergy patch, Omalizumab, demonstrating potential for future market entry.
List ofย Allergy Vaccineย companies in the market-
ALK (Denmark)
-
Stallergenes Greer (Switzerland)
-
Allergy Therapeutics (U.K.)
-
HAL Allergy B.V. (Netherlands)
-
HollisterStier Allergy (U.S.)
-
Zhejiang Wolwo Bio-pharmaceutical Co., Ltd (China)
-
LETIPharma (Spain)
-
Dermapharm Holding SE (Germany)